Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pathologie-Biologie|May 18, 2000
Methodological problems in evaluating efficacy of a treatment in multiple sclerosisE Waubant, D Goodkin
Revue Neurologique|June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]E Waubant, R Sloan, P B Andersson, et al.
Clinical Neuropathology|January 1, 1987
Etiology of pituitary apoplexy: review and case presentationR W Leech, D Goodkin, G Obert, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2001
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosisE Waubant, L Gee, K Miller, et al.
Neurology|January 15, 2003
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMSE Waubant, D Goodkin, A Bostrom, et al.
Journal of Neuroimmunology|December 8, 2000
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MSE Waubant, L Gee, P Bacchetti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 26, 2001
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)S F Leavey, K McCullough, E Hecking, et al.
Neuropediatrics|September 26, 2001
Interferon beta-1a in children with multiple sclerosis is well toleratedE Waubant, J Hietpas, T Stewart, et al.
Annals of Neurology|July 18, 2001
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisW I McDonald, A Compston, G Edan, et al.
Pageof 1